Department of Gastroenterology, West China Hospital of Sichuan University, Chengdu, People's Republic of China.
Sci Rep. 2021 Jan 14;11(1):1440. doi: 10.1038/s41598-021-81213-8.
Studies have demonstrated that inflammatory bowel disease (IBD) patients are at an increased risk of developing anxiety and/or depression. IBD patients with depression/anxiety have higher rates of hospitalization and increased disease severity than those without. So far, there is a paucity of data concerning the impact of anxiety/depression on Chinese IBD patients. The aim of this study was to find out the prevalence of symptoms of anxiety/depression in Chinese IBD population and its impact on IBD-related features. This is a cross-sectional study from the southwest China IBD referral center. Eligible participants were divided into those with symptoms of anxiety/depression and those without based on the Hospital Anxiety and Depression Scale (HADS). Demographic data and disease duration, IBD-related surgery, tobacco use, extra-intestinal manifestations, disease activity scores, endoscopic evaluation, laboratory data and current medication use were compared between two groups. A total of 341 IBD patients [221 Crohn's disease (CD) and 120 ulcerative colitis (UC)] were included. The prevalence of symptoms of anxiety/depression in IBD was 33.1%. CD patients with symptoms of anxiety/depression tended to have higher scores of simple endoscopic scores for Crohn's disease (SES-CD) (p = 0.0005). UC patients with symptoms of anxiety/depression had a significantly higher Mayo score (p = 0.0017) and ulcerative colitis endoscopic index of severity (UCEIS) (p < 0.0001) than their non-anxiety/depression counterparts. CD-related surgery (p = 0.012) and Crohn's disease activity index (CDAI) (p < 0.0001) were identified as independent risk factors for symptoms of anxiety/depression in CD, while corticosteroid use (p = 0.036) as an independent risk factor for symptoms of anxiety/depression in UC. This study helps our understanding of the prevalence of symptoms of anxiety/depression in IBD patients and its impact on IBD course and reminds us to pay more attention on IBD management with anxiety/depression.
研究表明,炎症性肠病(IBD)患者发生焦虑和/或抑郁的风险增加。患有抑郁/焦虑的 IBD 患者的住院率和疾病严重程度高于无抑郁/焦虑的患者。迄今为止,关于焦虑/抑郁对中国 IBD 患者的影响的数据很少。本研究旨在了解中国 IBD 人群中焦虑/抑郁症状的流行情况及其对 IBD 相关特征的影响。这是一项来自中国西南 IBD 转诊中心的横断面研究。根据医院焦虑和抑郁量表(HADS),将符合条件的参与者分为有焦虑/抑郁症状组和无焦虑/抑郁症状组。比较两组间人口统计学资料、疾病病程、IBD 相关手术、吸烟、肠外表现、疾病活动评分、内镜评估、实验室数据和当前用药情况。共纳入 341 例 IBD 患者[221 例克罗恩病(CD)和 120 例溃疡性结肠炎(UC)]。IBD 患者中焦虑/抑郁症状的患病率为 33.1%。有焦虑/抑郁症状的 CD 患者的简单克罗恩病内镜评分(SES-CD)评分较高(p=0.0005)。有焦虑/抑郁症状的 UC 患者的 Mayo 评分(p=0.0017)和溃疡性结肠炎内镜严重指数(UCEIS)评分(p<0.0001)明显高于无焦虑/抑郁症状的患者。CD 相关手术(p=0.012)和克罗恩病活动指数(CDAI)(p<0.0001)是 CD 患者出现焦虑/抑郁症状的独立危险因素,而皮质类固醇的使用(p=0.036)是 UC 患者出现焦虑/抑郁症状的独立危险因素。本研究有助于了解 IBD 患者焦虑/抑郁症状的流行情况及其对 IBD 病程的影响,并提醒我们更加关注伴焦虑/抑郁的 IBD 管理。